Vesigen Therapeutics
Vesigen’s patented technology uses ARRDC1 Mediated Microvesicles (ARMMs) to deliver intracellular therapeutics to previously undruggable targets.
Last updated on
Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps
Learn More!Vesigen’s patented technology uses ARRDC1 Mediated Microvesicles (ARMMs) to deliver intracellular therapeutics to previously undruggable targets.